跳至主要内容
临床试验/NCT03947346
NCT03947346已完成不适用

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2019年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
indicators of renal injury

研究概览

简要总结

The main purpose of this study is to learn more about biomarkers of kidney function in the blood and urine of neuroblastoma survivors. A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of neuroblastoma between 0-18 years of age
  • < 21 years of age at time of study enrollment
  • Two or more years from completion of systemic chemotherapy and/or radiation therapy

排除标准

  • Patients treated with observation only
  • Patients with multiple primary cancers

结局指标

主要结局

indicators of renal injury

时间窗: 2 years

urine collected from the first morning void will be used to assess urine creatinine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Biomarkers of Renal Dysfunction in Neuroblastoma... | 临床试验